Trial Profile
A Phase 2/3, multicenter, randomized, investigator-blinded study to evaluate the efficacy and safety of NK-104 versus Atorvastatin in Chinese patients with hypercholesterolaemia
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 13 Apr 2022
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kowa
- 20 May 2016 New trial record